Cannabis regulators in Massachusetts have modified a ban on marijuana vape products that will allow businesses to begin selling newly manufactured goods as soon as retailers can get them on the shelf. However, vape products manufactured before December 12 will remain under a quarantine imposed by the Massachusetts Cannabis Control Commission (CCC) on November 12.
Under the amended quarantine order, medical marijuana treatment centers and adult-use dispensaries will be permitted to sell devices that vaporize cannabis flower or concentrates provided that they comply with new regulations.
November’s quarantine order was issued in response to the outbreak of lung illnesses that has been dubbed e-cigarette or vaping product use-associated lung injury (EVALI) by health officials. In its ongoing investigation of the lung injuries, the Centers for Disease Control and Prevention has identified vitamin E acetate as a toxin of concern.
Shawn Collins, the executive director of the CCC, emphasized that the new regulations, which were put in place in the interest of consumer safety, only apply to products purchased from licensed retailers.
“These protections exist in the legal market,” he said. “They do not exist in the illicit market.”
New Rules Push Transparency
Dispensaries that carry cannabis vaping products will be